As such, loss of Hsf1 has been implicated in Huntington’s disease and increasing Hsf1 activity has been proposed as a therapeutic avenue for neurodegenerative disease with broad potential (14–16). The gene discussed is HSF1; the disease is neurodegenerative disease.